CPNE1 promotes non-small cell lung cancer progression by interacting with RACK1 via the MET signaling pathway.
Anqi WangWen YangYue LiYang ZhangJieqi ZhouRuochen ZhangWeijie ZhangJianjie ZhuYuanyuan ZengZeyi LiuJian-An HuangPublished in: Cell communication and signaling : CCS (2022)
Our findings show that CPNE1 promotes tumorigenesis by interacting with RACK1 and activating MET signaling. The combination of a MET inhibitor with an EGFR-TKI attenuated tumour growth more significantly than either single-drug treatment. These findings may provide new insights into the biological function of CPNE1 and the development of novel therapeutic strategies for NSCLC. Video Abstract.